Invention Grant
- Patent Title: Sustained release formulation comprising a somatostatin analogue
- Patent Title (中): 包含生长抑素类似物的缓释制剂
-
Application No.: US14265605Application Date: 2014-04-30
-
Publication No.: US09303067B2Publication Date: 2016-04-05
- Inventor: Olivier Lambert
- Applicant: Olivier Lambert
- Applicant Address: CH Basel
- Assignee: Novartis AG
- Current Assignee: Novartis AG
- Current Assignee Address: CH Basel
- Agent Michelle Han
- Priority: GB0428151.5 20041221
- Main IPC: C07K7/08
- IPC: C07K7/08 ; A61K9/00 ; A61K38/10 ; A61K9/08
Abstract:
A pharmaceutical composition for parenteral administration of a somatostatin analog salt of aspartate, e.g. mono- or diaspartate, lactate, succinate, e.g. mono- or disuccinate, acetate, glutamate, e.g. mono- or diglutamate or citrate and water forming a gelling depot system after injection in contact with the body fluid.
Public/Granted literature
- US20150038414A1 Organic Compounds Public/Granted day:2015-02-05
Information query
